A partnership to provide comprehensive perinatal mental health and parenting support for the first 1,000 days
The Raising Washington Initiative seeks to develop an evidence-based fully integrated perinatal support program that will offer mental health care, parent training and support services for the first 1,000 days of a baby’s life (conception through child’s 2nd birthday) for every high-risk baby born in Washington. This will include creating care pathways informed by the needs of patients and providers, navigators to help guide families through the many care transitions in the perinatal period and accessible information to keep parents and babies healthy.
To learn more this work, please contact Project Manager Lori Ferro, MHA at ljf9@uw.edu.
We are exploring the feasibility of establishing a long-term, residential Therapeutic Community in Washington State for adults living with schizophrenia, schizoaffective disorder, biplolar disorder and other serious mental illnesses. Such a facility would fill a critical gap in our current system, providing a complete spectrum of care for those in our community with chronic mental health conditions. Beyond offering patients and families a safe and therapeutic way to continue their recovery, we would hope to develop this program as a site of research and innovation and a site where we can teach and inspire the next generation of mental health care professionals for our state. Ultimately, we would like to help other communities build programs of their own.
This project aims to develop a clinical scaffolding system to enhance telemental health care by providing real-time coaching and actionable suggestions during video-based sessions. Modeled after live supervision methodologies, it supports clinicians by identifying intervention targets and offering text-based coaching prompts to guide care. Unlike automated chatbots, this approach enables clinicians to adapt suggestions to patient needs, balancing automation with oversight for safer AI-supported mental healthcare. The proposed in-session support will facilitate efficient implementation of strategies and clinician skill development. This project seeks to enhance data privacy by processing all data on-device and avoiding external data transfers.
The purpose of this project is to enhance the usefulness and cultural relevance of the Spanish version of the PMQ-9, a questionnaire that assesses manic symptoms in individuals with bipolar disorder.
The
ages of 18-25 years are ‘peak onset’ times of major depression and bipolar
disorder. These disorders have different courses and treatments, but diagnosing
bipolar disorder is difficult because manic symptoms occur less often than
depressive symptoms and many individuals do not recall manic symptoms. A
‘misdiagnosis lag’ of 8-10 years can contribute to prolonged periods of
potentially ineffective treatments and suboptimal outcomes such as high symptom
burden, relationship problems, educational attainment and occupational
functioning.
This project will use remote prospective assessment and monitoring of depressive and manic symptoms in at-risk patients in-between patient visits to increase the ‘data points’ clinicians have when assessing a bipolar disorder diagnosis. This is especially important for people at risk for bipolar disorder (for example those with a family history of bipolar disorder) because manic symptoms can be provoked by first-line medication treatments for major depression. The project will use a new manic symptom measure (the Patient Mania Questionnaire-9) and a commonly used depressive symptom measure (the Patient Health Questionnaire-9) to monitor symptoms, and learn how clinicians and patients use this information clinically.
The goals of this project are to 1) determine which validated bipolar disorder patient-reported symptom measure is most acceptable and helpful to patients and clinicians in clinical care, 2) demonstrate that the preferred measure can be used to monitor outcomes with high fidelity in routine care, and 3) assess the feasibility of comparing effectiveness of measurement-based care (MBC) to usual care in a randomized trial.
The primary goal of this project is to quantitatively compare the treatment experience, engagement, self-reported clinical outcomes, and recovery-oriented outcomes of patients initially randomized to telepsychiatry collaborative care and telepsychiatry enhanced referral. In addition, for the subset of patients randomized to telepsychiatry enhanced referral who do not engage in treatment and are still symptomatic at 6 months, an additional goal is to quantitatively compare the treatment experience, treatment engagement, self-reported clinical outcomes and recovery-oriented outcomes of patients randomized to continued- telepsychiatry enhanced referral or phone enhanced referral. Additional goals are to gain an in-depth understanding of patients’ and providers’ treatment experiences and to examine treatment heterogeneity among subgroups of patients based on race/ethnicity, age and clinical severity.
